谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

BRIM‐P: A Phase I, Open‐label, Multicenter, Dose‐escalation Study of Vemurafenib in Pediatric Patients with Surgically Incurable, BRAF Mutation‐positive Melanoma

Julia C. Chisholm,Jozef Suvada,Ira J. Dunkel,Michela Casanova,Weijiang Zhang, Natasha Ritchie,YounJeong Choi, Jane Park,Meghna Das Thakur,Stephen Simko,Nga Wan Rachel Tam,Andrea Ferrari

Pediatric Blood & Cancer（2018）

引用 32|浏览41
关键词
BRAF mutation,clinical trial,melanoma,oncology,pediatric,vemurafenib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要